40 reports

It has been predicted that the rate of cancer is expected to increase by about ##% by 2020, which will lead to the discovery of potential drugs to treat cancer.

  • Cholesterol
  • World
  • Forecast
  • Archer Daniels Midland Company
  • Cargill Inc.

CANCER MORTALITY FOR SELECTED SITES IN ## COUNTRIES (1950-##).

  • Cholesterol
  • AstraZeneca PLC
  • Cerenis
  • Merck & Co., Inc.
  • The Medicines Company

MARKET ##.

  • Cholesterol
  • APAC
  • Japan
  • United States
  • World

You can easily book an appointment with one online.

  • Cardiovascular Disease
  • Cholesterol
  • Lipid Modifying Drug
  • Statins
  • AstraZeneca PLC

Plos One; ##(##): ##-##.

  • Cholesterol
  • China
  • Germany
  • United States
  • Forecast

Geographic Coverage France, Germany, Italy, Japan, Spain, UK, USA Market Segmentation Centralized Testing - Hospitals - Commercial/ Private Laboratories POC/ Decentralized Testing - Physician Offices/ Group Practices - Ambulatory Care Centers - ICUs/ CCUs - Cancer Clinics -

  • Cholesterol
  • France
  • Japan
  • United States
  • Forecast

Geographic Coverage France, Germany, Italy, Japan, Spain, UK, USA Market Segmentation Centralized Testing - Hospitals - Commercial/ Private Laboratories POC/ Decentralized Testing - Physician Offices/ Group Practices - Ambulatory Care Centers - ICUs/ CCUs - Cancer Clinics -

  • Cholesterol
  • France
  • Japan
  • United States
  • Forecast

Drivers and their Impact Impact on Key Customer Category Increase in Incidence of High Cholesterol Increase in Prevalence of Chronic Diseases Changes in Cholesterol Treatment Guidelines Increase in Aging Population Expected Entry of Cost- Effective OTC Versions ## ## ## ## ## Hospitals Low Low

  • Cholesterol
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • SIZE OF THE MARKET

Figure ##-## Percent of U. S.

  • Cholesterol
  • Abaxis, Inc.
  • Alere Inc.
  • PTS DIAGNOSTICS
  • Roche Group

CANCER MORTALITY FOR SELECTED SITES IN ## COUNTRIES (1950-##).

  • Cholesterol
  • World
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Pfizer Inc.

Further clinical data on at least one of the other targeted cancers.

  • Cholesterol
  • Clinical Trial
  • Diagnostics
  • United States
  • GlobalData's company

CANCER MORTALITY FOR SELECTED SITES IN ## COUNTRIES (1950-##).

  • Cholesterol
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc.

CANCER MORTALITY FOR SELECTED SITES IN ## COUNTRIES (1950-##).

  • Cholesterol
  • World
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Pfizer Inc.

In relation to cancer risk, the EAS guidelines draw on evidence from animal and cell studies to suggest a protective role of sitosterol against certain cancers, and thus to dismiss cancer risk with recommended daily intakes of functional foods containing ##-##g/ day of p

  • Cholesterol
  • World
  • Danone SA
  • Raisio Group
  • Unilever PLC

CANCER MORTALITY FOR SELECTED SITES IN ## COUNTRIES (1950-##).

  • Cholesterol
  • World
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Pfizer Inc.

CANCER MORTALITY FOR SELECTED SITES IN ## COUNTRIES (1950-##).

  • Cholesterol
  • World
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Pfizer Inc.

MARKET ##.

  • Cholesterol
  • APAC
  • United States
  • World
  • Company Financials
  • BEXAROTENE - DRUG PROFILE

The molecules developed by Companies in Phase II, Phase I and Preclinical stages are ##, ## and ## respectively.

  • Cholesterol
  • Therapy
  • United States
  • Product Initiative
  • LipimetiX Development LLC

The molecules developed by companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are ##, ##, ##, ## and ## respectively.

  • Cardiology
  • Cardiovascular Disease
  • Cholesterol
  • Pharmaceutical
  • Pfizer Inc.
  • Pipeline by Amgen Inc., H1 2016

The molecules developed by companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are ##, ##, ##, ## and ## respectively.

  • Cardiology
  • Cardiovascular Disease
  • Cholesterol
  • Therapy
  • Pfizer Inc.
  • AF-122 - Drug Profile

The company' s products include proprietary molecules, natural new chemical entities, biomarkers, metabolite, and anti cancer drugs.

  • Cholesterol
  • United States
  • Company Operations
  • Product Initiative
  • Vitae Pharmaceuticals, Inc.
  • Pipeline by Amgen Inc., H1 2016

It provides prescription medicines for the treatment of diabetes, hemophilia, harmone dificiency, high blood pressure, ulcers, skin ailments, cancer, allergy, and others.

  • Cholesterol
  • South Korea
  • Turkey
  • World
  • Product Initiative

The company develops tumor activated prosoft drugs for cancer.

  • Cholesterol
  • Therapy
  • World
  • Product Initiative
  • Cerenis
  • DYSLIPIDEMIA - PIPELINE BY GILEAD SCIENCES INC, H1 2018
  • DYSLIPIDEMIA - PIPELINE BY KOTOBUKI PHARMACEUTICAL CO LTD, H1 2018

Its pipeline products are used in the treatment of stomach cancer, lung cancer, eating disorder, angina, hair loss and musculoskeletal system disorder.

  • Cardiovascular Disease
  • Cholesterol
  • Chronic Disease
  • Pharmaceutical
  • Amarin Corporation plc

His research interests have spanned many fields including genomics, heart disease, cancer, kidney disease, diabetes, ophthalmology, and neurodegenerative diseases.

  • Cholesterol
  • Therapy
  • United States
  • Company
  • Gemphire Therapeutics Inc.

Alvogen develops medicines for senile diseases such as cancer, high blood pressure, diabetes, stroke, heart disease, Alzheimers, metabolic diseases, and others.

  • Cholesterol
  • Lipid Modifying Drug
  • United States
  • Product Initiative
  • Merck & Co., Inc.

Alvogen develops medicines for senile diseases such as cancer, high blood pressure, diabetes, stroke, heart disease, Alzheimer' s, metabolic diseases, and others.

  • Cholesterol
  • South Korea
  • United States
  • World
  • Product Initiative

The company develops tumor activated prosoft drugs for cancer.

  • Cholesterol
  • Therapy
  • World
  • Product Initiative
  • Cerenis

THE COMPANY DEVELOPS TUMOR ACTIVATED PROSOFT DRUGS FOR CANCER.

  • Cholesterol
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative
  • DYSLIPIDEMIA - PIPELINE BY GOLDEN BIOTECHNOLOGY CORP, H2 2018
  • Indication Name

Its pipeline products are used in the treatment of stomach cancer, lung cancer, eating disorder, angina, hair loss and musculoskeletal system disorder.

  • Cholesterol
  • Chronic Disease
  • United States
  • Product Initiative
  • Amarin Corporation plc